Live Breaking News & Updates on Patients With Small Cell Lung Cancer

Stay updated with breaking news from Patients with small cell lung cancer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Lurbinectedin Displays Superior Risk/Benefit Ratio Over Topotecan in SCLC

Lurbinectedin demonstrated greater activity and a superior safety profile vs topotecan in a subset of small cell lung cancer. ....

Phase 3 Atlantis Trial , Patients With Small Cell Lung Cancer , Chemotherapy Free Interval , Central Nervous System Metastases , Accelerated Approval From The Fda , Alkylating Agent ,

Dr Leal on the Development of DLL3-Targeted Agents in SCLC

Ticiana Leal, MD, discusses the variety of DLL3-targeted agents in development for patients with small cell lung cancer and neuroendocrine tumors. ....

Department Of Hematology , Emory University School Of Medicine , Thoracic Medical Oncology Program , Ticiana Leal , Medical Oncology , Emory University School , Lung Cancer Conference , Per Winter Lung Cancer Conference , Dll3 Targeted Agents , Patients With Small Cell Lung Cancer , Neuroendocrine Tumors ,

Dr Gondi on Prophylactic Cranial Irradiation With Hippocampal Avoidance in SCLC

Vinai Gondi, MD, discusses efficacy and safety findings from the phase 2/3 NRG-CC003 trial of prophylactic cranial irradiation in patients with small cell lung cancer. ....

Proton Center , Brain Tumor Center , Vinai Gondi , Radiation Oncology , Northwestern Medicine West Region , Nrg Cc003 Trial , Prophylactic Cranial Irradiation , Patients With Small Cell Lung Cancer , Northwestern Medicine West Region And Proton Center ,

Dr Johnson on the Initial Efficacy of Ifinatamab Deruxtecan in Refractory SCLC

Melissa L. Johnson, MD, discusses findings from a subgroup analysis of outcomes with ifinatamab deruxtecan in patients with refractory small cell lung cancer, which she presented at the 2023 IASLC World Conference on Lung Cancer. ....

Melissal Johnson , Oncology Department , Lung Cancer Research , Sarah Cannon Research Institute , Tristar Centennial Medical Center , Medical Executive Committee , Patients With Small Cell Lung Cancer , Infinatamab Deruxtecan , I Dxd Ds 7300 , 2023 Iaslc World Conference On Lung Cancer ,

Dr Johnson on ABBV-011 in Small Cell Lung Cancer

Melissa L. Johnson, MD, discusses the development of the seizure-related homolog protein 6–targeting antibody-drug conjugate ABBV-011 and outcomes with this agent in patients with small cell lung cancer. ....

Melissal Johnson , Tristar Centennial Medical Center , Sarah Cannon Research Institute , Lung Cancer Research , Oncology Department , Medical Executive Committee , Abbv 011 , Patients With Small Cell Lung Cancer ,